Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 8, 2007, Pages 871-876

  Gonçalves, Roberto Martins ^a   Rodrigues, David Henrique ^a   da Costa, Alinne Maria Camargos ^a   Teixeira, Mauro Martins ^a   Campos, Wesley Ribeiro ^a   Oréfice, Fernando ^a   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chemokines; Posterior uveitis; Retinochoroiditis; Toxoplasmosis

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; FOLINIC ACID; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE;

ADULT; ARTICLE; CHORIORETINITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INJURY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TOXOPLASMIC RETINOCHOROIDITIS; TOXOPLASMOSIS; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIPROTOZOAL AGENTS; CHORIORETINITIS; FEMALE; HUMANS; INTERLEUKIN-8; LEUCOVORIN; MALE; OPTIC DISK; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE; TOXOPLASMOSIS, OCULAR; VASCULITIS; VISUAL ACUITY;

EID: 36348997222     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00943.x     Document Type: Article

References (36)

1. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F & Addiss DJ (2003): Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis 9: 55-62.
2. Becker MD, O'Rourke LM, Blackman WS, Planck SR & Rosenbaum JT (2000): Reduced leucocyte migration, but normal rolling and arrest, in the IL-8 receptor homologue of knock-out mice. Invest Ophthalmol Vis Sci 41: 1812-1827.
3. Bonfioli AA & Orefice F (2005): Toxoplasmosis. Semin Ophthalmol 20: 129-141.
4. Charo IF & Ransohoff RM (2006): The many roles of chemokines and chemokines receptors in inflammation. N Engl J Med 354: 610-621.
5. Crane IJ, Wallace CA, McKillop-Smith S & Forrester JV (2000): Control of chemokine production at the blood-retina barrier. Immunology 101: 426-433.
6. Curnow SJ, Falciani F, Durrani OM et al. (2005): Multiplex bead immunoassay analysis of aqueous humour reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 46: 4251-4259.
7. Denney CF, Eckmann L & Reed S (1999): Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infect Immun 67: 1547-1552.
8. El-Asrar AMA, Struyf S, Al-Kharashi SA, Missotten L, van Damme J & Geboes K (2000): Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol 84: 1360-1366.
9. El-Asrar AMA, Struyf S, Descamps FJ et al. (2004): Chemokines and gelatinases in the aqueous humour of patients with active uveitis. Am J Ophthalmol 138: 401-411.
10. Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Streiter RM, Kunkel SL (1997): Human retinal pigment epithelial cell interleukin-8 and monocyte chemoattractant protein-1 modulation by T and lymphocyte products. Invest Ophthalmol Vis Sci 38: 446-455.
11. Elner SG, Streiter RM, Bian ZM, Kunkel SL, Mokhtarzaden L, Johnson M, Lukacs NW & Elner VM (1998): Interferon-induced protein-10 and interleukin-8: CXC chemokines present in proliferative diabetic retinopathy. Arch Ophthalmol 116: 1597-1601.
12. Ferom EJ, Klaren VN, Wterenga EA, Verjans GM & Kijlstra A (2001): Characterization of Toxoplasma gondii - specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis. Invest Ophthalmol Vis Sci 42: 3228-3232.
13. Freire AL, Bertolo MB, Pinho AJ Jr, Sâmara AM & Fernandes SEM (2004): Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease. Clin Rheumatol 23: 203-205.
14. Glasner PD, Silveira C, Kruszon-Moran D et al. (1992): An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 114: 136-144.
15. Holland GN (2003A: Ocular toxoplasmosis: a global reassessment. Part I. Epidemiology and course of disease. Am J Ophthalmol 136: 973-988.
16. Holland GN (2004A: Ocular toxoplasmosis: a global reassessment. Part II. Disease manifestations and management. Am J Ophthalmol 137: 1-17.
17. Holtkamp GM, De Vos AF, Peek R & Kijlstra A (1999): Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGFb2) by human retinal pigment epithelial cells. Clin Exp Immunol 118: 35-40.
18. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T & McAuley JB (2001): Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154: 357-365.
19. Katsantonis J, Adler Y, Orfanos CE & Zouboulis CC (2000): Adamantiades-Behcet's disease: Serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201: 37-39.
20. Kimura SJ, Thygeson P & Hogan J (1959): Signs and symptoms of uveitis. Classification of the posterior manifestations of uveitis. Am J Ophthalmol 47: 171-176.
21. Klok AM, Luyendijk L, Zaal MJW, Rothova A, Hack CE & Kijlstra A (1998): Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol 82: 871-874.
22. Koppe JG & Rothova A (1989): Congenital toxoplasmosis. A longterm follow-up of 20 years. Int Ophthalmol 13: 387-390.
23. Kurtz RM, Elner VM, Bian ZM, Streiter RM, Kunkel SL & Elner SG (1997): Dexamethasone and cyclosporine A modulation of human retinal pigment epithelial cell monocyte chemotactic protein-1 and interleukin-8. Invest Ophthalmol Vis Sci 38: 436-445.
24. Leonardi A, Jose PJ, Zhan H & Calder VL (2003): Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology 110: 487-492.
25. Mantas C, Direskeneli H, Oz D, Yavuz S & Akoglu T (2000): IL-8 producing cells in patients with Behcet's disease. Clin Exp Rheumatol 18: 249-251.
26. Miyazawa I, Abe T, Narikawa K et al. (2005): Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. J Neuroimmunol 158: 240-244.
27. Moreira MA, Tilbery CP, Monteiro LP, Teixeira MM & Teixeira AL (2006): Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. Acta Neurol Scand 114: 109-113.
28. Murdoch C & Finn A (2000): Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043.
29. Rothova A (2003): Ocular manifestations of toxoplasmosis. Curr Opin Ophthalmol 14: 384-388.
30. Sousa-Pereira SR, Teixeira AL, Silva LC, Souza AL, Antunes CM, Teixeira MM & Lambertucci JR (2006): Serum and cerebral spinal fluid levels of chemokines and Th2 cytokines in Schistosoma mansoni myeloradiculopathy. Parasite Immunol 28: 473-478.
31. Takeuchi M, Oh-i K, Suzuki J et al. (2006): Elevated serum levels of CXCL9/monokine induced by interferon-γ and CXCL10/ interferon-γ-inducible protein-10 in ocular sarcoidosis. Invest Ophthalmol Vis Sci 47: 1063-1068.
32. Verma MJ, Lloyd A, Rager H, Streiter R, Kunkel S, Taub D & Wakefield D (1997): Chemokines in acute anterior uveitis. Curr Eye Res 16: 1202-1208.
33. Verma MJ, Mukaida N, Vollmer-Conna U, Matsushima K, Lloyd A & Wakefield D (1999): Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment. Invest Ophthalmol Vis Sci 40: 2465-2470.
34. Wallace GR, Curnow SJ, Wloka K, Salmon M & Murray PI (2004): The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res 23: 435-448.
35. Wallace GR, Farmer I, Church A, Graham EM & Stanford MR (2003): Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis. Immunol Lett 90: 59-64.
36. Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y & Miyashita E (1997): The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behcet's disease. Arch Dermatol Res 298: 444-447.